UNUSUAL GLOMERULAR LESION IN A PATIENT RECEIVING LONG-TERM INTERFERON-ALPHA

被引:40
|
作者
LEDERER, E [1 ]
TRUONG, L [1 ]
机构
[1] BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030
关键词
INTERFERON-ALPHA; NEPHROTIC SYNDROME; LEUKEMIA;
D O I
10.1016/S0272-6386(12)70268-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 60-year-old man with long-standing chronic myelogenous leukemia presented with renal insufficiency and proteinuria after more than 6 years of therapy with daily interferon alpha injections. He also manifested unusual skin lesions and a low-titer antinuclear antibody (ANA). Percutaneous renal biopsy disclosed an unusual glomerular lesion characterized by global, diffuse, and marked widening of the lamina rara interna, and focal segmental mesangial proliferation. Discontinuation of the drug resulted in resolution of the proteinuria, but not the renal insufficiency. These glomerular changes have not been reported previously as a complication of this form of malignancy and are similar to lesions reported in newborn rats and mice receiving interferon alpha. The potential role of interferon alpha in the development of this glomerular disease is discussed. © 1992, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:516 / 518
页数:3
相关论文
共 50 条
  • [1] LONG-TERM REMISSION IN A PATIENT WITH ERYTHROLEUKEMIA FOLLOWING INTERFERON-ALPHA TREATMENT
    STEGER, GG
    DITTRICH, C
    CHOTT, A
    DERFLER, K
    SCHWARZMEIER, JD
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (04): : 351 - 354
  • [2] LONG-TERM RESPONSE TO INTERFERON-ALPHA IN A PATIENT WITH SYSTEMIC MASTOCYTOSIS AND CHRONIC MYELOMONOCYTIC LEUKEMIA
    PULIK, M
    LIONNET, F
    PETIT, A
    GENET, P
    GAULIER, A
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (01) : 66 - 66
  • [3] Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-alpha
    Lohr, HF
    Godderz, W
    Wolfe, T
    Heike, M
    Knuth, A
    zumBuschenfelde, KHM
    Dippold, W
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2427 - 2428
  • [4] LONG-TERM THERAPY WITH INTERFERON-ALPHA IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    WEHMEIER, A
    MEIERKORD, F
    SCHNEIDER, W
    [J]. BLOOD, 1994, 84 (10) : A58 - A58
  • [5] Long-term interferon-alpha therapy induces autoantibodies against epidermis
    Fleischmann, M
    Celerier, P
    Bernard, P
    Litoux, P
    Dreno, B
    [J]. DERMATOLOGY, 1996, 192 (01) : 50 - 55
  • [6] Long-term efficacy of Interferon-alpha in chronic inflammatory demyelinating polyneuropathy
    Giovanni Pavesi
    Luigi Cattaneo
    Adriana Marbini
    Franco Gemignani
    Domenico Mancia
    [J]. Journal of Neurology, 2002, 249 : 777 - 779
  • [7] Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy
    Pavesi, G
    Cattaneo, L
    Marbini, A
    Gemignani, F
    Mancia, D
    [J]. JOURNAL OF NEUROLOGY, 2002, 249 (06) : 777 - 779
  • [8] Long-term pegylated interferon-alpha and its potential in the treatment of melanoma
    Dummer, Reinhard
    Mangana, Joanna
    [J]. BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 169 - 182
  • [9] Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
    Sánchez, A
    Tobío, M
    González, L
    Fabra, A
    Alonso, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (3-4) : 221 - 229
  • [10] LONG-TERM OUTCOME OF INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-B
    DIBISCEGLIE, AM
    [J]. JOURNAL OF HEPATOLOGY, 1995, 22 : 65 - 67